Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update
Alps Group Inc, a Malaysia-based integrated biotechnology platform, announced a 44% revenue increase to $4.9 million for fiscal year 2026, alongside strategic developments including commencement of Nasdaq trading under ticker ALPS following a business combination. The company advanced its cellular therapy pipeline, expanded laboratory accreditation…